We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
WhiteSwell, an Israeli-Irish medical technology startup company pioneering new ways to treat acute decompensated heart failure, has announced the close of a $30 million series B funding round